004720 팜젠사이언스

기본 정보

• 섹터: KOSPI:제약
• 시가총액: 661억원 (2026-06-30 기준)
• 첫 등장: — (마커 미등장)
• 태그: 매크로/바이오헬스 · 매크로/소비미디어 · 전문의약품 · 소화기치료제 · 바이오신약 · 건강기능식품
• 네이버 금융: 🔗

기업개요

• 동사는 1966년 설립되어 소화기 치료제 중심의 제약사업과 건강기능식품 중심의 헬스케어사업을 영위하고 있음.
• 경기도 화성시에 본점과 생산시설을 두고, 6개 도매지점, 9개 전국 지점, 글로벌 R&D센터를 운영하며 전문의약품, 일반의약품 및 신약개발에 힘쓰고 있음.
• 주요 제품으로는 에소맥스정(궤양치료제), 바르디핀정(고혈압치료제), 리바틴정, 크바젯정(고지혈증 치료제), 세파클러(항생제), 네프리스엔(신장질환치료제) 등이 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자	전일 종가	종가	등락률	시간외	vol	색깔	smart	외	연	금투	투	개	그외
2026-08-07	3,245	3,270	🔴 +0.77%	—	×0.4	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	+0.0
2026-08-06	3,245	3,245	⚪ +0.00%	—	×0.3	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-08-05	3,325	3,245	🔵 -2.41%	—	×0.8	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.1	+0.1
2026-08-04	3,330	3,325	🔵 -0.15%	—	×0.7	⚫ 그외	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.0	+0.1
2026-08-03	3,250	3,330	🔴 +2.46%	—	×0.7	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-31	3,150	3,250	🔴 +3.17%	—	×0.6	⚫ 그외	-0.1억	-0.1	+0.0	-0.0	+0.0	+0.0	+0.1
2026-07-30	3,190	3,150	🔵 -1.25%	—	×0.5	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-29	3,275	3,190	🔵 -2.60%	—	×1.4	⚫ 그외	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.6	+0.5
2026-07-28	3,450	3,275	🔵 -5.07%	—	×1.0	⚫ 그외	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.3	+0.2
2026-07-27	3,440	3,450	🔴 +0.29%	—	×0.3	🔻 개인	-0.1억	-0.1	+0.0	-0.0	+0.0	+0.1	+0.0
2026-07-24	3,475	3,440	🔵 -1.01%	—	×0.7	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.4	+0.2
2026-07-23	3,380	3,475	🔴 +2.81%	—	×0.6	⚫ 그외	-0.0억	-0.0	+0.0	+0.0	+0.0	-0.4	+0.4
2026-07-22	3,480	3,380	🔵 -2.87%	—	×0.7	⚫ 그외	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.1	+0.1
2026-07-21	3,325	3,480	🔴 +4.66%	—	×1.2	🟢 외인	+0.4억	+0.4	+0.0	+0.0	+0.0	-0.6	+0.2
2026-07-20	3,400	3,325	🔵 -2.21%	—	×1.2	⚫ 그외	-0.5억	-0.5	+0.0	+0.0	+0.0	-0.4	+0.8
2026-07-16	3,360	3,400	🔴 +1.19%	—	×1.5	⚫ 그외	+0.4억	+0.4	+0.0	+0.0	+0.0	-0.9	+0.5
2026-07-15	3,045	3,360	🔴 +10.34%	—	×1.6	🟢 외인	+0.6억	+0.6	+0.0	+0.0	+0.0	-0.7	+0.1
2026-07-14	2,965	3,045	🔴 +2.70%	—	×4.3	⚫ 그외	+0.1억	+0.1	+0.0	+0.0	+0.0	-1.1	+1.0
2026-07-13	3,050	2,965	🔵 -2.79%	—	×0.7	⚫ 그외	-0.0억	-0.0	+0.0	+0.0	+0.0	-0.2	+0.2
2026-07-10	3,070	3,050	🔵 -0.65%	—	×0.5	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-07-09	3,200	3,070	🔵 -4.06%	—	×0.3	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-07-08	3,115	3,200	🔴 +2.73%	—	×0.9	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.2	+0.1
2026-07-07	3,165	3,115	🔵 -1.58%	—	×0.4	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	-0.0
2026-07-06	3,190	3,165	🔵 -0.78%	—	×0.7	⚫ 그외	-0.1억	-0.1	+0.0	+0.0	+0.0	-0.3	+0.4
2026-07-03	3,115	3,190	🔴 +2.41%	—	×1.0	🟢 외인	+0.2억	+0.2	+0.0	-0.0	+0.0	-0.2	+0.0
2026-07-02	3,050	3,115	🔴 +2.13%	—	×0.8	⚫ 그외	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.1	+0.1
2026-07-01	2,920	3,050	🔴 +4.45%	—	×0.8	⚫ 그외	-0.2억	-0.2	+0.0	+0.0	+0.0	-0.3	+0.6
2026-06-30	3,030	2,920	🔵 -3.63%	—	×0.3	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	+0.0
2026-06-29	2,870	3,030	🔴 +5.57%	—	×0.4	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-06-26	2,925	2,870	🔵 -1.88%	—	×0.6	⚫ 그외	-0.1억	-0.1	+0.0	+0.0	+0.0	-0.1	+0.2
2026-06-25	2,820	2,925	🔴 +3.72%	—	×0.6	⚫ 그외	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.3	+0.2

일자별 사유 (최신 위)

2026-07-15

• 사유: 제약 테마 강세 편승
• 섹터 컨텍스트: KOSPI:제약 (smart +554억)
• 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)